ALX Oncology Holdings Inc.

ALXO

Healthcare Biotechnology

EPS
+73.5%
Free cash flow
+31.7%
Total debt
−3.34%

Quarter to June 2026, against a year earlier

1.16 0.01 +0.87%
Market cap
$159.7M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
n/a
ROIC
−673.3%
Net debt / EBITDA
0.3×
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
66.52 50.73 145.56 143.46
Total non-current assets
16.21 8.32 32.76 17.36
Total Assets
82.72 59.05 178.33 160.82
Total current liabilities
27.72 24.55 20.18 14.78
Total non-current liabilities
10.20 8.51 6.80 9.86
Total liabilities
37.92 33.07 26.98 24.63
Common Equity (Total)
44.80 25.98 151.35 136.19
Shareholders Equity (Total)
44.80 25.98 151.35 136.19
Total Debt
10.11 9.75 8.51 9.71

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 26 Oct 2026